Nursing -NR 566 Final Exam Questions With
Complete Solution1 Latest Update 2025
1. drugs affecting the endocrine system -
ANSWERbiophosphates, hypothalamic and pituitary hormones,
exocrine pancreatic enzymes, diabetic agents, thyroid and
antithyroid agents
2. endocrine glands - ANSWERhypothalamic pituitary system,
thyroid and parathyroid glands, pancreas, adrenal glands, bone
formation, growth formation, metabolic rate control,
carbohydrate c h o metabolism, blood pressure control
3. hypothalamic - pituitary system - ANSWERThe biological
system responsible for the stress response; stress set off a
complex chain of events in the body
-TRH releases TSH
-GNRH releases FSH releases luteinizing hormone
--PRH releases prolactin
-oxytocin
-ADH
4. thyroid and parathyroid glands - ANSWERregulate
metabolic and calcium rate
-TH, thieroglobulin, parathyroid hormone
5. Pancreas - ANSWERAn organs in the abdominal cavity with
two roles. The first is an exocrine role: to produce digestive
enzymes and bicarbonate, which are delivered to the small
,intestine via the pancreatic duct. The second is an endocrine
role: to secrete insulin and glucagon into the bloodstream to help
regulate blood glucose levels.
exocrine: tripcinogen, chymotrypsin, amylase, lipase
endocrine: insulin, glucagon
6. adrenal glands - ANSWERcortisol, aldosterone, estrogen,
androgens
7. bone formation - ANSWERparathyroid hormone (pth):
calcium, phosphorus
growth formation - ANSWERestrogens, androgens, testosterone
growth hormone releasing hormone releases GH (somatropin)
metabolic rate control - ANSWERTSH, TH
carbohydrate metabolism - ANSWERinsulin, glucagon
blood pressure control - ANSWERcortisol, aldosterone, ADH
what are biophosphates used for - ANSWERosteoporosis and
pagets disease
biophosphate drugs - ANSWERalendronate (fosamax),
risendronate (actonel)
8. pharmacodynamics of biophosphates - ANSWERinhibits
osteoclastic activity, increases bone density.
beneficial effects on bone density mass increase rapidly the first
year of treatment, then plateau after 2 to 3 years
, significant gastrointestinal and esophageal irritation
9. biophosphate ADRs - ANSWERsignificant gastrointestinal
and esophageal irritation, strong renal impact (monitor for renal
issues), arthralgia, myalgia, headache, rash, afib
**monitor for pathological fractures and osteonecrosis of the
jaw
10. biophosphate drug interactions - ANSWERranitidine
doubles alendronate (fosamax) bioavailability
biophosphate rational drug selection - ANSWERcorrect
prexisting but d deficiency/hypocalcemia prior to therapy
IV used for GI intolerance and bone metastasis
biophosphate high-risk patients - ANSWERwhites, asians, hx of
eating disorders, long-term steroid or thyroid meds use
biophosphates labs and imaging - ANSWERCBC, CMP, LFTs,
bone density scan
biophosphate monotoring - ANSWERalkaline phosphatase
levels (bone breakdown), calcium and electrolytes (esp on
diuretics)
biophosphate patient education - ANSWERtake with a full
glass of water in AM on empty stomach, remain upright for
30mins after taking, no antacids/alcohol, have adequate vit d and
calcium intake